Jade Biosciences, Inc. (JBIO) stock
JBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$15.40+0.06 (+0.42%)
Close on Nov 17, 2026Market cap $979.40MP/E –Yield –
Jade Biosciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Jade Biosciences's price to book ratio was 2.4× on Nov 11, 2026, against 2.3× a year earlier. Over the last 4 years it ranged from 1.3× to 262.5×, with a median of 72.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.4× | −0.4 |
| 2025 | Dec 31, 2025 | 2.8× | −16.7 |
| 2024 | Jul 31, 2024 | 19.6× | −154.7 |
| 2023 | Dec 29, 2023 | 174.2× | −6.4 |
| 2022 | Dec 30, 2022 | 180.6× | +124.6 |
| 2021 | Dec 31, 2021 | 56.0× | – |
See a number that looks wrong?